2 Patents
- US120496392024Cancer Immunotherapy by Delivering Class II MHC Antigens Using a Vlp-replicon
The USA, As Represented By The Secretary, Dept. Of Health And Human Services
0 cites - US117188612023Cancer Immunotherapy by Delivering Class II MHC Antigens Using a Vlp-replicon
The USA, As Represented By The Secretary, Dept. Of Health And Human Services
0 cites